Search results

  1. Promoting mental wellbeing at work

    Everything NICE has said on promoting mental wellbeing at work through productive and healthy working conditions in an interactive flowchart

  2. Diverticular disease

    Everything NICE has said on diverticular disease in an interactive flowchart

  3. Unintentional injuries among under-15s

    Preventing unintentional injuries among under-15s in the home, on the road and in outdoor play and leisure environments.

  4. Familial breast cancer

    Everything NICE has said on assessing and managing familial breast cancer and related risks in people with a family history in an interactive flowchart

  5. Fever in under 5s

    Everything NICE has said on assessing and initiating management of fever with no obvious cause in children under 5 in an interactive flowchart

  6. Maternal and child nutrition

    Everything NICE has said on maternal and child nutrition in an interactive flowchart

  7. Violence and aggression

    Everything NICE has said on managing violence in mental health, health and community settings in an interactive flowchart

  8. Harmful sexual behaviour among children and young people

    Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.

  9. Medicines optimisation

    Everything NICE has said on shared decision-making and processes to optimise medicines and support adherence in an interactive flowchart

  10. Familial hypercholesterolaemia

    Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart

  11. Ectopic pregnancy and miscarriage

    Everything NICE has said on diagnosing and managing tubal ectopic pregnancy and miscarriage in early pregnancy in an interactive flowchart.

  12. Glaucoma

    Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart

  13. Tuberculosis

    Everything NICE has said on preventing, diagnosing and managing latent and active tuberculosis in an interactive flowchart

  14. InterDry for intertrigo (MIB192)

    NICE has developed a medtech innovation briefing (MIB) on InterDry for intertrigo

  15. Suicide prevention

    Everything NICE has said on preventing suicide in community and residential custodial and detention settings in an interactive flowchart

  16. Shared decision making (KTT23)

    This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

  17. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  18. Safer insulin prescribing (KTT20)

    This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  19. Multimorbidity and polypharmacy (KTT18)

    This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  20. Antimicrobial stewardship: prescribing antibiotics (KTT9)

    This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  21. Antipsychotics in people living with dementia (KTT7)

    This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  22. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  23. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .